198 related articles for article (PubMed ID: 26840958)
1. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
Christensen B; Sørensen ES
J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
Gao YA; Agnihotri R; Vary CP; Liaw L
Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
[TBL] [Abstract][Full Text] [Related]
4. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
Christensen B; Schack L; Kläning E; Sørensen ES
J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
[TBL] [Abstract][Full Text] [Related]
6. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L; Leung LL; Morser J
Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
[TBL] [Abstract][Full Text] [Related]
7. Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment.
Shao Z; Morser J; Leung LLK
J Biol Chem; 2014 Sep; 289(39):27146-27158. PubMed ID: 25112870
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
[TBL] [Abstract][Full Text] [Related]
9. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
[TBL] [Abstract][Full Text] [Related]
10. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences.
Kon S; Yokosaki Y; Maeda M; Segawa T; Horikoshi Y; Tsukagoshi H; Rashid MM; Morimoto J; Inobe M; Shijubo N; Chambers AF; Uede T
J Cell Biochem; 2002; 84(2):420-32. PubMed ID: 11787071
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis.
Sharif SA; Du X; Myles T; Song JJ; Price E; Lee DM; Goodman SB; Nagashima M; Morser J; Robinson WH; Leung LL
Arthritis Rheum; 2009 Oct; 60(10):2902-12. PubMed ID: 19790060
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
13. Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Peraramelli S; Zhou Q; Zhou Q; Wanko B; Zhao L; Nishimura T; Leung TH; Mizuno S; Ito M; Myles T; Stulnig TM; Morser J; Leung LLK
J Thromb Haemost; 2022 May; 20(5):1256-1270. PubMed ID: 35108449
[TBL] [Abstract][Full Text] [Related]
14. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.
Yamamoto N; Sakai F; Kon S; Morimoto J; Kimura C; Yamazaki H; Okazaki I; Seki N; Fujii T; Uede T
J Clin Invest; 2003 Jul; 112(2):181-8. PubMed ID: 12865407
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
16. The carboxyl-terminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion.
Takahashi K; Takahashi F; Tanabe KK; Takahashi H; Fukuchi Y
Biochem Mol Biol Int; 1998 Dec; 46(6):1081-92. PubMed ID: 9891840
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
[TBL] [Abstract][Full Text] [Related]
18. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.
Kon S; Nakayama Y; Matsumoto N; Ito K; Kanayama M; Kimura C; Kouro H; Ashitomi D; Matsuda T; Uede T
PLoS One; 2014; 9(12):e116210. PubMed ID: 25545242
[TBL] [Abstract][Full Text] [Related]
19. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration.
Ito K; Kon S; Nakayama Y; Kurotaki D; Saito Y; Kanayama M; Kimura C; Diao H; Morimoto J; Matsui Y; Uede T
Matrix Biol; 2009 Jan; 28(1):11-9. PubMed ID: 19000758
[TBL] [Abstract][Full Text] [Related]
20. A regulated interaction between alpha5beta1 integrin and osteopontin.
Barry ST; Ludbrook SB; Murrison E; Horgan CM
Biochem Biophys Res Commun; 2000 Jan; 267(3):764-9. PubMed ID: 10673366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
